
Anzu Partners
Description
Anzu Partners is a Washington, D.C.-based investment firm specializing in breakthrough industrial and life science technology companies, often referred to as "deep tech" or "hard tech." Founded in 2014, the firm focuses on companies developing and commercializing disruptive technologies with strong intellectual property and a clear path to market. Anzu Partners distinguishes itself by providing not only capital but also strategic guidance and operational support to help its portfolio companies scale their innovative solutions.
The firm has demonstrated a consistent ability to raise substantial capital, reflecting investor confidence in its specialized investment thesis. In March 2023, Anzu Partners announced the close of its third fund, Anzu Industrial Technologies Fund III, with $500 million in commitments. This follows their successful Anzu Industrial Technologies Fund II, which closed at $200 million in March 2021, and their initial Fund I at $100 million in 2017. Cumulatively, Anzu Partners has raised over $800 million across these three dedicated funds, enabling them to make significant investments in capital-intensive deep technology ventures.
Anzu Partners typically leads Series A and Series B funding rounds, targeting companies that have disruptive technology, a significant market opportunity, and a strong management team. Their initial check sizes for lead investments generally range from $10 million to $30 million. For instance, they led a $10 million Series A round for Axion BioSystems in 2018 and a $30 million Series B for Precision NanoSystems in 2021, showcasing their flexibility in investment size depending on the company's stage and capital needs. The firm's portfolio spans various sectors within industrial and life sciences, including advanced materials, photonics, robotics, and biotech tools.
Investor Profile
Anzu Partners has backed more than 74 startups, with 3 new investments in the last 12 months alone. The firm has led 39 rounds, about 53% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Canada, Singapore.
- Strong thematic focus on Manufacturing, Biotechnology, Software.
- Led 1 rounds in the past year.
- Typical check size: $10M – $30M.
Stage Focus
- Series A (30%)
- Series B (26%)
- Series Unknown (18%)
- Seed (9%)
- Convertible Note (5%)
- Private Equity (3%)
- Series C (3%)
- Series D (3%)
- Grant (1%)
- Post Ipo Debt (1%)
Country Focus
- United States (81%)
- Canada (9%)
- Singapore (4%)
- Australia (3%)
- Italy (3%)
Industry Focus
- Manufacturing
- Biotechnology
- Software
- Health Care
- Electronics
- Life Science
- Medical
- Energy
- Semiconductor
- Battery
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.